Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
Clinical trial NCT00045110 · COMPLETED
Trial details
- NCT number
- NCT00045110
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-08-01
- Primary completion
- 2010-12-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.